shutterstock_2055997766_michael_vi

Michael Vi / Shutterstock.com

4 August 2022MedtechStaff Writer

J&J unit primed for multi-million dollar damages over counterfeits

Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

US govt bodies unite to battle fake pharma

22 December 2022 Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

J&J units launch prostate cancer drug suit

31 May 2022 Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

More on this story

US govt bodies unite to battle fake pharma

22 December 2022 Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

J&J units launch prostate cancer drug suit

31 May 2022 Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

More on this story

US govt bodies unite to battle fake pharma

22 December 2022 Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

J&J units launch prostate cancer drug suit

31 May 2022 Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB